A novel Shiga toxin 2a neutralizing antibody therapeutic with low immunogenicity and high efficacy.
Antimicrob Agents Chemother
; 68(1): e0059823, 2024 Jan 10.
Article
in En
| MEDLINE
| ID: mdl-38047751
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Escherichia coli Infections
/
Shiga-Toxigenic Escherichia coli
/
Hemolytic-Uremic Syndrome
Limits:
Adult
/
Animals
/
Humans
Language:
En
Journal:
Antimicrob Agents Chemother
Year:
2024
Document type:
Article
Affiliation country:
Estados Unidos
Country of publication:
Estados Unidos